Mini-review series on cancer-associated thrombotic disease
Authors . | Affiliations . | Review title . |
---|---|---|
Jasmijn F. Timp,1 Sigrid K. Braekkan,2 Henri H. Versteeg,1 and Suzanne C. Cannegieter1 | 1Leiden University Medical Center; 2University of Tromsø | Epidemiology of cancer-associated venous thrombosis |
Julia E. Geddings and Nigel Mackman | University of North Carolina | Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients |
Ingrid Pabinger, Johannes Thaler, and Cihan Ay | Medical University of Vienna | Biomarkers for prediction of venous thromboembolism in cancer |
Tiziano Barbui, Guido Finazzi, and Anna Falanga | Hospital Papa Giovanni XXIII | Myeloproliferative neoplasms and thrombosis |
Agnes Y. Y. Lee and Erica A. Peterson | University of British Columbia | Treatment of cancer-associated thrombosis |
Authors . | Affiliations . | Review title . |
---|---|---|
Jasmijn F. Timp,1 Sigrid K. Braekkan,2 Henri H. Versteeg,1 and Suzanne C. Cannegieter1 | 1Leiden University Medical Center; 2University of Tromsø | Epidemiology of cancer-associated venous thrombosis |
Julia E. Geddings and Nigel Mackman | University of North Carolina | Tumor-derived tissue factor–positive microparticles and venous thrombosis in cancer patients |
Ingrid Pabinger, Johannes Thaler, and Cihan Ay | Medical University of Vienna | Biomarkers for prediction of venous thromboembolism in cancer |
Tiziano Barbui, Guido Finazzi, and Anna Falanga | Hospital Papa Giovanni XXIII | Myeloproliferative neoplasms and thrombosis |
Agnes Y. Y. Lee and Erica A. Peterson | University of British Columbia | Treatment of cancer-associated thrombosis |